{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:48:47Z","timestamp":1785167327571,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003151","name":"Fonds de recherche du Quebec Nature et technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-06173"],"award-info":[{"award-number":["RGPIN-2017-06173"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["173408"],"award-info":[{"award-number":["173408"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:33:23Z","timestamp":1738280003000},"page":"354-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["3D-printed radiopaque episcleral plaques with radioactive collimating cavities for enhanced dose delivery in brachytherapy"],"prefix":"10.1016","volume":"24","author":[{"given":"Souheib","family":"Zekraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-3907","authenticated-orcid":false,"given":"Th\u00e9ophraste","family":"Lescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdokht","family":"Akbari Taemeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-466X","authenticated-orcid":false,"given":"Marc-Andr\u00e9","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.12.001_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","article-title":"Radiation therapy for choroidal melanoma","volume":"42","author":"Finger","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0004","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of task group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0005","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41433-020-01295-y","article-title":"Clinical outcomes of modified collaborative ocular melanoma study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma","volume":"35","author":"Xu","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.brachy.2024.12.001_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/acm2.12966","article-title":"Optic disc dose reduction in ocular brachytherapy using (125) I notched COMS plaques: A simulation study based on current clinical practice","volume":"21","author":"Lee","year":"2020","journal-title":"J Appl Clin Med Phys"},{"issue":"5","key":"10.1016\/j.brachy.2024.12.001_bib0007","doi-asserted-by":"crossref","first-page":"e13902","DOI":"10.1002\/acm2.13902","article-title":"Transitioning from a COMS-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience","volume":"24","author":"Meltsner","year":"2023","journal-title":"J Appl Clin Med Phys."},{"key":"10.1016\/j.brachy.2024.12.001_bib0008","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.12.001_bib0009","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1118\/1.1812605","article-title":"Dosimetric study of the 15 mm ROPES eye plaque","volume":"31","author":"Granero","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0008-4182(04)80004-8","article-title":"Pathological and prognostic features of uveal melanomas","volume":"39","author":"McLean","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02713680490908634","article-title":"Pe'er J. Ultrasonographic tissue characteristics of mushroom-shaped uveal melanoma","volume":"30","author":"Kaiserman","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.brachy.2024.12.001_bib0012","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma, III: iinitial mortality findings: COMS report No. 18","volume":"119","year":"2001","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.brachy.2024.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0014","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.12.001_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0016","unstructured":"Eye Physics LEPPMaPILA, CA: eye Physics, LLC; [cited 2024 Sep 25]. Available from: https:\/\/www.eyephysics.com. Eye Physics Plaque Models and Products. Los Alamitos, CA. 2024."},{"key":"10.1016\/j.brachy.2024.12.001_bib0017","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review","volume":"17","author":"Le","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300528","article-title":"Tumor shape-specific brachytherapy implants by 3D-printing, precision radioactivity painting, and biomedical imaging","volume":"12","author":"Lescot","year":"2023","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.brachy.2024.12.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/503645","article-title":"Variations in eyeball diameters of the healthy adults","volume":"2014","author":"Bekerman","year":"2014","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0021","unstructured":"Souheib Zekraoui TL, Mahdokht Akbari Taemeh, Marc-Andr\u00e9 Fortin. Fabrication of radiopaque polymer composites via fused filament Fabrication (FFF) 3D printing. Additive Manufacturing (submitted as of Jan. 2025)."},{"key":"10.1016\/j.brachy.2024.12.001_bib0022","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0023","unstructured":"Methods. ISsLt. ISO 9978:2020 _radiation protection \u2014 Sealed sources \u2014 Leakage test methods; https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:9978:ed-2:v1:en. Accessed September 5, 2024."},{"issue":"6","key":"10.1016\/j.brachy.2024.12.001_bib0024","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.brachy.2024.08.036","article-title":"MSOR2. Presentation Time: 5:05 PM: Dosimetric gel and methodology for 3D visualization of dose profiles generated by personalized low-dose-rate brachytherapy devices","volume":"23","author":"Taemeh","year":"2024","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.001_bib0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1118\/1.3523614","article-title":"Comparison of dose calculation methods for brachytherapy of intraocular tumors","volume":"38","author":"Rivard","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0026","unstructured":"Plaque Simulator, Version 6.4.5 (Eye Physics, LLC, Los Alamitos, CA, USA) [Internet]. Available from: https:\/\/www.eyephysics.com\/PS\/PS6\/UserGuide\/EP1821.html. 2024. Accessed September 24, 2024."},{"key":"10.1016\/j.brachy.2024.12.001_bib0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and adverse events of plaque brachytherapy for ocular melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.12.001_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40135-023-00313-y","article-title":"Radiation retinopathy","volume":"11","author":"Chen","year":"2023","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.brachy.2024.12.001_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2005.01.022","article-title":"Radiation complications and tumor control after <SUP>125<\/SUP>I plaque brachytherapy for ocular melanoma","volume":"63","author":"Jensen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jamaophthalmol.2013.4422","article-title":"Outcomes of choroidal melanomas treated with eye physics: a 20-year review","volume":"131","author":"Berry","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2024.12.001_bib0031","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2011.08.017","article-title":"A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve","volume":"119","author":"Finger","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.12.001_bib0032","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye (Lond)"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:38:29Z","timestamp":1740746309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124004641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538472124004641"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D-printed radiopaque episcleral plaques with radioactive collimating cavities for enhanced dose delivery in brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}